| Torrance Memorial Physician Network | |
|
2900 Lomita Blvd Torrance CA 90505-5102 | |
| (310) 784-3740 | |
| (310) 539-1006 |
| Full Name | Torrance Memorial Physician Network |
|---|---|
| Speciality | Internal Medicine |
| Location | 2900 Lomita Blvd, Torrance, California |
| Authorized Official Name and Position | Heidi Assigal (VICE PRESIDENT) |
| Authorized Official Contact | 3102577205 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Torrance Memorial Physician Network 23326 Hawthorne Blvd Ste 200 Torrance CA 90505-3756 Ph: (310) 257-7205 | Torrance Memorial Physician Network 2900 Lomita Blvd Torrance CA 90505-5102 Ph: (310) 784-3740 |
| NPI Number | 1003312620 |
|---|---|
| Provider Enumeration Date | 04/03/2018 |
| Last Update Date | 04/10/2024 |
| Medicare PECOS PAC ID | 1355302134 |
|---|---|
| Medicare Enrollment ID | O20180725002297 |
News Archive
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
Dynasil Corporation of America today announced record financial results for its 2010 third quarter, which ended June 30, 2010. The Company posted record revenue for the 2010 third quarter of $11.3 million which compares to $8.5 million in the third-quarter of 2009, a 33% increase year over year. Operating income, net income and diluted earnings per share for the quarter were $1.33 million, $727,646, and $0.05, increases of 92%, 85%, and 120%, respectively, compared with the prior year.
The National Alliance on Mental Illness has unveiled NAMI AIR, a unique iPhone and Android app to provide support and access to information both for persons living with mental health conditions and for family members, friends and other caregivers.
Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy of therapeutic interventions at each stage, according to a study to be published in Cell Stem Cell.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003312620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
News Archive
Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.
Dynasil Corporation of America today announced record financial results for its 2010 third quarter, which ended June 30, 2010. The Company posted record revenue for the 2010 third quarter of $11.3 million which compares to $8.5 million in the third-quarter of 2009, a 33% increase year over year. Operating income, net income and diluted earnings per share for the quarter were $1.33 million, $727,646, and $0.05, increases of 92%, 85%, and 120%, respectively, compared with the prior year.
The National Alliance on Mental Illness has unveiled NAMI AIR, a unique iPhone and Android app to provide support and access to information both for persons living with mental health conditions and for family members, friends and other caregivers.
Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy of therapeutic interventions at each stage, according to a study to be published in Cell Stem Cell.
› Verified 3 days ago
Southbay Endocrine Medical Associates Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 20911 Earl St, Suite 340, Torrance, CA 90503 Phone: 310-802-7002 Fax: 310-542-4695 | |
Delamo Family Medical Group Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3475 Torrance Blvd Ste G, Torrance, CA 90503 Phone: 310-543-1695 Fax: 310-792-2321 | |
Dunja Maglica Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23441 Madison St Ste 305, Torrance, CA 90505 Phone: 310-378-5115 Fax: 310-378-9779 | |
David H. Stern, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1218 Crenshaw Blvd, Torrance, CA 90501 Phone: 310-328-1181 Fax: 310-328-1747 | |
Medical Associates Of Little Company Of Mary Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 21311 Madrona Ave, 100a, Torrance, CA 90503 Phone: 310-792-4400 Fax: 310-542-5805 | |
Bliss Medical Group, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 23451 Madison St, Suite 250, Torrance, CA 90505 Phone: 310-791-0083 Fax: 310-791-0085 |